Bristol-Myers Squibb

Keytruda, Opdivo near new cancer uses where they won't butt heads
Fierce Pharma
Fri, 04/15/16 - 08:39 am
Keytruda
Opdivo
Bristol-Myers Squibb
Merck
Hodgkin's lymphoma
head and neck cancer
Drug giant plots Bay area expansion, 150 more jobs
Bizjournals.com
Thu, 04/14/16 - 01:29 pm
Bristol-Myers Squibb
hirings
expansion
California
cancer immunotherapy
U.S. Food and Drug Administration Accepts for Priority Review Bristol-Myers Squibb’s Supplemental Biologics License Application for Opdivo® (nivolumab) for the Treatment of Classical Hodgkin Lymphoma Patients
Yahoo
Thu, 04/14/16 - 09:13 am
Bristol-Myers Squibb
Opdivo
Hodgkin's lymphoma
FDA
Two drug makers complain India is thwarting licenses for selling generics
Stat
Wed, 04/13/16 - 11:46 am
India
Lee Pharma
BDR Pharma
generics
Sprycel
Bristol-Myers Squibb
AstraZeneca
Onglyza
New myeloma meds work better than the old, but they're far too expensive: Report
Fierce Biotech
Tue, 04/12/16 - 03:39 pm
Multiple Myeloma
Bristol-Myers Squibb
Amgen
Takeda
Empliciti
Kyprolis
Ninlaro
Celgene
Revlimid
3 Nominations for Big Pharma's Riskiest Pipeline -- and Why They Qualify
Motley Fool
Tue, 04/12/16 - 10:37 am
GSK
oncology
Bristol-Myers Squibb
AstraZeneca
Bristol-Myers Squibb Is Crushing Its Competition In The Cancer Treatment Market
Seeking Alpha
Mon, 04/4/16 - 07:57 am
Bristol-Myers Squibb
cancer
oncology
Merck
Opdivo
Can Bristol-Myers Win the Autoimmune Market with Padlock Acquisition?
Bidness, ETC
Mon, 03/28/16 - 08:46 am
Bristol-Myers Squibb
Padlock Therapeutics
autoimmune disease
M&A
​​Behind Bristol-Myers' $600M acquisition of an Atlas biotech startup
Bizjournals.com
Wed, 03/23/16 - 04:17 pm
Bristol-Myers Squibb
Padlock Therapeutics
M&A
J&J, BMS are delivering solid sales from new meds. The rest of Big Pharma, not so much: Forbes
Fierce Pharma
Tue, 03/22/16 - 10:04 am
Big Pharma
JNJ
Bristol-Myers Squibb
Cholesterol pill boosts cancer immunotherapy, at least in mice
Yahoo/Reuters
Thu, 03/17/16 - 05:03 pm
Opdivo
Keytruda
Avasimibe
Merck
Bristol-Myers Squibb
cancer immunotherapy
Pfizer
Why This Bristol-Myers Cancer Drug Is Crushing Its Rivals
Fortune
Wed, 03/16/16 - 10:16 am
Bristol-Myers Squibb
Opdivo
Merck's Keytruda held back by docs who don't want to wait for diagnostics
Fierce Pharma Marketing
Mon, 03/14/16 - 05:59 pm
Merck
Keytruda
physicians
Opdivo
Bristol-Myers Squibb
Bristol-Myers Squibb’s Opdivo: Why Is It Important?
Yahoo/Market Realist
Thu, 03/10/16 - 09:32 pm
Bristol-Myers Squibb
Opdivo
A Look at Bristol-Myers Squibb’s Oncology Segment
Yahoo/Market Realist
Thu, 03/10/16 - 09:58 am
Bristol-Myers Squibb
oncology
Bristol-Myers prints a pair of 'Golden Tickets' for Cambridge biotech startups
Fierce Biotech
Tue, 03/8/16 - 10:22 am
Bristol-Myers Squibb
LabCentral
R&D
Bristol-Myers Squibb says stops some initiatives in China
Yahoo/Reuters
Tue, 03/8/16 - 10:18 am
Bristol-Myers Squibb
China
GSK
This $150,000 Cancer Treatment Saved a Pharma Company
Bloomberg
Fri, 03/4/16 - 02:12 pm
Ono Pharmaceutical
Opdivo
Bristol-Myers Squibb
Japan
Drugmakers partner in immuno-oncology, to better capture market share
Medical Marketing and Media
Wed, 03/2/16 - 11:00 am
Opdivo
immuno-oncology
Bristol-Myers Squibb
Eli Lilly
Merck
Roche
AstraZeneca
Novartis
Rivals chase Bristol-Myers in cancer immunotherapy drug race
Yahoo/Reuters
Fri, 02/26/16 - 11:09 am
Bristol-Myers Squibb
cancer immunotherapy
Roche
AstraZeneca
Merck
Opdivo

Pages